Nabriva Therapeutics plc
NBRVF
$0.0001
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.18M | 1.80M | 12.41M | 14.65M | 20.04M |
| Total Receivables | 4.44M | 10.51M | 6.74M | 12.39M | 12.36M |
| Inventory | -- | 9.03M | 9.68M | 17.33M | 15.54M |
| Prepaid Expenses | 3.26M | 2.24M | 2.15M | 3.07M | 6.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 73.00K | 123.00K | 123.00K | 121.00K | 122.00K |
| Total Current Assets | 9.95M | 23.69M | 31.10M | 47.56M | 54.30M |
|
|
|||||
| Total Current Assets | 9.95M | 23.69M | 31.10M | 47.56M | 54.30M |
| Net Property, Plant & Equipment | 246.00K | 263.00K | 280.00K | 293.00K | 206.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.00K | 2.00K | 3.00K | 7.00K | 13.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 379.00K | 379.00K | 378.00K | 377.00K | 378.00K |
| Total Assets | 10.58M | 24.34M | 31.77M | 48.24M | 54.89M |
|
|
|||||
| Total Accounts Payable | 14.03M | 6.98M | 5.43M | 3.90M | 1.07M |
| Total Accrued Expenses | 7.90M | 10.48M | 7.15M | 9.68M | 8.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 196.00K | 197.00K | 4.83M | 5.73M | 6.62M |
| Total Finance Division Other Current Liabilities | 4.08M | 10.34M | 10.19M | 2.33M | 2.92M |
| Total Other Current Liabilities | 4.08M | 10.34M | 10.19M | 2.33M | 2.92M |
| Total Current Liabilities | 26.20M | 28.00M | 27.61M | 21.64M | 19.33M |
|
|
|||||
| Total Current Liabilities | 26.20M | 28.00M | 27.61M | 21.64M | 19.33M |
| Long-Term Debt | 344.00K | 345.00K | 388.00K | 399.00K | 512.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 352.00K | 352.00K | 479.00K | 578.00K | 444.00K |
| Total Liabilities | 26.90M | 28.70M | 28.47M | 22.62M | 20.29M |
|
|
|||||
| Common Stock & APIC | 657.28M | 657.18M | 656.13M | 655.68M | 653.15M |
| Retained Earnings | -673.62M | -661.56M | -652.86M | -630.08M | -618.57M |
| Treasury Stock & Other | 27.00K | 27.00K | 27.00K | 27.00K | 27.00K |
| Total Common Equity | -16.32M | -4.36M | 3.29M | 25.62M | 34.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.32M | -4.36M | 3.29M | 25.62M | 34.61M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.32M | -4.36M | 3.29M | 25.62M | 34.61M |
|
|
|||||